Literature DB >> 3042621

Haemophilus influenzae type b vaccine.

J R Gilsdorf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042621     DOI: 10.1007/BF02722184

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  26 in total

1.  Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age.

Authors:  M Lepow; M Randolph; R Cimma; D Larsen; M Rogan; J Schumacher; B Lent; S Gaintner; J Samuelson; L Gordon
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

2.  Hemophilus type b polysaccharide vaccine. Committee on Infectious Diseases.

Authors: 
Journal:  Pediatrics       Date:  1985-08       Impact factor: 7.124

3.  Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.

Authors:  M L Lepow; J S Samuelson; L K Gordon
Journal:  J Pediatr       Date:  1985-02       Impact factor: 4.406

4.  Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

Authors:  H Peltola; H Käyhty; M Virtanen; P H Mäkelä
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

5.  Neonatal passive immunization by maternal vaccination.

Authors:  M S Amstey; R A Insel; M E Pichichero
Journal:  Obstet Gynecol       Date:  1984-01       Impact factor: 7.661

6.  Age-related response to two Haemophilus influenzae type b vaccines.

Authors:  D J Pincus; D Morrison; C Andrews; E Lawrence; S H Sell; P F Wright
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

7.  Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.

Authors:  J Eskola; H Peltola; A K Takala; H Käyhty; M Hakulinen; V Karanko; E Kela; P Rekola; P R Rönnberg; J S Samuelson
Journal:  N Engl J Med       Date:  1987-09-17       Impact factor: 91.245

8.  Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.

Authors:  P Anderson; G Peter; R B Johnston; L H Wetterlow; D H Smith
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

9.  Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.

Authors:  H Peltola; H Käyhty; A Sivonen; H Mäkelä
Journal:  Pediatrics       Date:  1977-11       Impact factor: 7.124

10.  Passive immunization against disease due to Haemophilus influenzae type b: concentrations of antibody to capsular polysaccharide in high-risk children.

Authors:  D M Ambrosino; S H Landesman; C C Gorham; G R Siber
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.